Avita Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Avita Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avita Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avita Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $1.2M | 222k | 5.29 |
| 2024-12-31 | $1.1M | 85k | 12.80 |
| 2024-09-30 | $1.0M | 97k | 10.72 |
| 2024-06-30 | $860k | 109k | 7.92 |
| 2024-03-31 | $638k | 40k | 16.03 |
| 2023-12-31 | $855k | 62k | 13.72 |
| 2023-09-30 | $2.3M | 159k | 14.61 |
| 2023-06-30 | $613k | 36k | 17.01 |
| 2022-12-31 | $118k | 18k | 6.60 |
| 2022-06-30 | $290k | 68k | 4.30 |
| 2022-03-31 | $298k | 35k | 8.56 |
| 2021-06-30 | $0 | 38k | 0.00 |
| 2020-12-31 | $249k | 13k | 18.54 |
| 2020-09-30 | $344k | 14k | 25.19 |
| 2020-06-30 | $452k | 15k | 30.52 |